Personalis Inc. (04X)
XDUS
Real-time Data
06:00 AM
Day's Range
12.0352 wk Range
3.77Overview - 04X - Personalis Inc.
Key Statistics
Valuation
Enterprise Value
-84.29M
P/E (Trailing)
‪-15.98‬
PEG Ratio
‪-0.52‬
Price / Book
‪6.52‬
EV / EBITDA
‪1.18‬
Profitability
Gross Margin
‪21.21%‬
Profit Margin
‪22.65%‬
Operating Margin
‪-116.36%‬
Return on Assets
‪-24.32%‬
Return on Equity
‪-31.11%‬
Ownership
Shares Outstanding
106.36M
Price stats
50-Day Avg
‪11.55‬
200-Day Avg
‪8.10‬
Peers - 04X - Personalis Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- 04XXDUSPersonalis Inc.+66.42%52-week change-13.21P/E (Trailing)‪22.65%‬Profit Margin
- NL0XDUSGrail, Inc.+57.14%52-week change-5.92P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+82.13%52-week change-101.08P/E (Trailing)‪50.72%‬Profit Margin
- 1K9XDUSCareDx Inc.+74.13%52-week change-109.00P/E (Trailing)‪67.55%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+64.09%52-week change-41.53P/E (Trailing)‪64.46%‬Profit Margin
- NG9XDUSNeoGenomics Inc.+61.51%52-week change-16.39P/E (Trailing)‪43.21%‬Profit Margin
- NG2XDUSNeogen Corporation+51.76%52-week change-245.65P/E (Trailing)‪46.93%‬Profit Margin
Profile Summary - 04X - Personalis Inc.
About
Personalis Inc. is a biotechnology company specializing in advanced genomics services for precision medicine and oncology. Its primary function is to analyze complex genetic information for clinical and academic research, aiding in the development of targeted therapeutics and personalized treatments. The company's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
